| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/21/2001 | EP1076696A2 Human receptor molecules |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | EP1076566A1 ATTENUATED MUTANTS OF $i(SALMONELLA) WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN |
| 02/21/2001 | EP1076563A1 Dipeptide caspase inhibitors and the use thereof |
| 02/21/2001 | EP1076557A1 Ccr-3 receptor antagonists |
| 02/21/2001 | EP1076553A2 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and uses |
| 02/21/2001 | EP0580635B2 Modified plant viruses as vectors |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 02/21/2001 | CN1284943A Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/21/2001 | CN1284942A Matrix metalloprotease inhibitors |
| 02/21/2001 | CN1284885A Vaccine |
| 02/21/2001 | CN1284884A 疫苗 Vaccine |
| 02/21/2001 | CN1284883A Method to enhance an immune response of nucleic acid vaccination |
| 02/21/2001 | CN1284874A 5-HT1F agonists |
| 02/21/2001 | CN1284379A Production process of salt algae powder and preparation of salt algae powder capsule |
| 02/21/2001 | CN1284366A Preparation of life prolonging preparation |
| 02/21/2001 | CN1284359A Women's tonic wine and its preparation |
| 02/21/2001 | CN1284358A Men's tonic wine and its preparation |
| 02/21/2001 | CN1284357A Yichun wine and its preparation |
| 02/21/2001 | CN1284341A Immune regulator of amino acid calcium from turtle shell and its preparation |
| 02/21/2001 | CN1062182C Novel physiologically active substance |
| 02/21/2001 | CN1062138C RNA from poultry embryo and its medical use |
| 02/20/2001 | US6191271 Synthetic divalent sLex containing polylactosamines and methods for use |
| 02/20/2001 | US6191160 Spiro-indolines as Y5 receptor antagonists |
| 02/20/2001 | US6191135 Respiratory system disorders, antiinflammatory agents; analgesics |
| 02/20/2001 | US6191127 Antiinflammatory agents, autoimmune diseases, cardiovascular disorders, nervous system disorders |
| 02/20/2001 | US6191112 Human therapeutic uses of BPI protein products |
| 02/20/2001 | US6191104 Methods of treating graft rejection with the IL-17 receptor |
| 02/20/2001 | US6190909 TH2-specific gene |
| 02/20/2001 | US6190875 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 02/20/2001 | US6190723 Neutralization of food allergens by thioredoxin |
| 02/20/2001 | US6190685 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 02/20/2001 | US6190671 Drug, particularly an immunomodulator, containing non-fructifying, non-photosynthetic filamentous bacteria envelopes or fractions thereof, and preparation thereof |
| 02/20/2001 | US6190670 Eliciting an immune response to a hapten in an animal by administering to animal effective amount of hapten in association with an effective amount of modified c-reactive protein (mcrp) or a mutant-mcrp |
| 02/20/2001 | US6190669 Attenuated mutants of salmonella which constitutively express the Vi antigen |
| 02/20/2001 | US6190656 Activating mammalian immune system entails series of il-2 administrations that are effected intermittently over an extended period; each administration of il-2 is sufficient to allow spontaneous dna synthesis; measuring dna synthesis |
| 02/20/2001 | CA2223624C Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines |
| 02/20/2001 | CA2197233C Methods of identifying compounds useful for treating autoimmune diseases |
| 02/20/2001 | CA2192289C Substituted heterocyclic derivatives |
| 02/20/2001 | CA2191789C Biaromatic compounds containing an adamantyl group in ortho position; pharmaceutical and cosmetic compositions containing them and use thereof |
| 02/20/2001 | CA2110797C Modified sialyl lewis x compounds |
| 02/20/2001 | CA2072658C Use of honey as vaccine |
| 02/18/2001 | CA2302913A1 Therapeutic composition for allergic dermatitis |
| 02/15/2001 | WO2001011366A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 02/15/2001 | WO2001011067A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011027A1 New protein |
| 02/15/2001 | WO2001011024A2 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | WO2001010987A1 Grapeseed, cold-pressed grape oil, crushed grape and grape flour |
| 02/15/2001 | WO2001010912A1 Multiple cytokine-antibody complexes |
| 02/15/2001 | WO2001010866A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 02/15/2001 | WO2001010865A1 p38MAP KINASE INHIBITORS |
| 02/15/2001 | WO2001010838A1 Multivalent compounds |
| 02/15/2001 | WO2001010837A1 Multivalent sulfonamides |
| 02/15/2001 | WO2001010833A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 02/15/2001 | WO2001010831A1 Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists |
| 02/15/2001 | WO2001010829A1 Novel vitamin d analogues |
| 02/15/2001 | WO2001010816A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/15/2001 | WO2001010444A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | WO2001010439A1 Cyclic amine ccr3 antagonists |
| 02/15/2001 | WO2001010434A1 Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field |
| 02/15/2001 | WO2001010423A2 Use of 5-ht3 receptor antagonists for the treatment of inflammations of the respiratory tract |
| 02/15/2001 | WO2001010421A1 Drug releasing biodegradable fiber implant |
| 02/15/2001 | WO2001010409A1 Aqueous nasal formulation |
| 02/15/2001 | WO2001010385A2 1,4-substituted 4,4-diaryl cyclohexanes |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | WO2001010381A2 Methods for treating or preventing pain and anxiety |
| 02/15/2001 | WO2001010221A1 Vaccines for the treatment of autoimmune disease |
| 02/15/2001 | WO2000066158A3 Use of cytokines and mitogens to inhibit pathological immune responses |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000061184A3 Dry formulation for transcutaneous immunization |
| 02/15/2001 | WO2000059497A8 Pyrrolidine modulators of chemokine receptor activity |
| 02/15/2001 | WO2000059483A3 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 02/15/2001 | WO2000057920A3 Method for expressing proteins |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000049144A3 Pyk2 binding proteins |
| 02/15/2001 | WO2000043419A3 Exocytosis pathway proteins and methods of use |
| 02/15/2001 | DE19937656A1 Verwendung von Antithrombin III zur Prophylaxe und Therapie von Erkrankungen The use of antithrombin III for the prophylaxis and treatment of diseases |
| 02/15/2001 | DE19936719A1 Substituierte 1,5-Dihydropyrrol-2-on-Derivate Substituted 1,5-dihydropyrrol-2-one derivatives |
| 02/15/2001 | DE19936521A1 Substituierte Pyrrolidin-2,3,4-trion-3-oxim-Derivate Substituted pyrrolidine-2,3,4-trione-3-oxime Derivatives |
| 02/15/2001 | CA2382659A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | CA2381910A1 Novel vitamin d analogues |
| 02/15/2001 | CA2381293A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | CA2381290A1 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2381215A1 P38map kinase inhibitors |
| 02/15/2001 | CA2381033A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 02/15/2001 | CA2380973A1 Substituted pyrrolidine-2-3,4-trione 3-oxime derivatives which are active as nmda receptor antagonists |
| 02/15/2001 | CA2380759A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 02/15/2001 | CA2378990A1 1,4-substituted 4,4-diaryl cyclohexanes |
| 02/15/2001 | CA2378499A1 Cyclic amine ccr3 antagonists |
| 02/15/2001 | CA2378481A1 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | CA2378285A1 Vaccines for the treatment of autoimmune disease |
| 02/14/2001 | EP1075840A2 Therapeutic and prophylactic uses of antithrombin III |
| 02/14/2001 | EP1075529A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 02/14/2001 | EP1075519A2 Inhibitors of nf-kb activation |
| 02/14/2001 | EP1075518A2 Human transcriptional regulator molecules |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |